Considering that activation of the ERBB2/RAS signaling pathway in prostate cancer cells may affect their growth rates, which could influence the analysis to assess their metastatic potentials, we carried out a growth curve assay using asynchronous cells. Here, ERBB2 is linked to prostate carcinoma.